Trump-时代的HHS报告以证据不足和潜在伤害为由,质疑对未成年人的性别确认治疗的安全性。 A Trump-era HHS report questions the safety of gender-affirming treatments for minors, citing insufficient evidence and potential harms.

2025年11月19日发表的一份由特朗普行政委托、同行审查的报告认为,没有足够的科学证据支持对未成年人使用青春期阻塞剂和交叉性激素,并列举了潜在的长期伤害和缺乏可靠数据。 A Trump administration-commissioned, peer-reviewed report released on November 19, 2025, concludes there is insufficient scientific evidence to support the use of puberty blockers and cross-sex hormones for minors, citing potential long-term harms and lack of robust data. 卫生与公众服务部公布了九名合著者的姓名,所有合著者均对儿科性别护理持有案可查的怀疑态度,并指出调查结果表明需要谨慎行事。 The Department of Health and Human Services (HHS) released the names of nine coauthors, all with documented skepticism toward pediatric gender care, and stated the findings reflect a need for caution. 该报告没有美国儿科学会和内分泌学会等主要医疗团体参加,引发了关于青年性别护理的辩论。 The report, which was not participated in by major medical groups like the American Academy of Pediatrics and the Endocrine Society, has sparked debate over youth gender care. 大约在同一时间,政府效率部 (DOGE) 取消了超过21亿美元的NIH资助,包括LGBTQ+青年健康和跨性别动物研究项目,理由是纳税人浪费. Around the same time, the Department of Government Efficiency (DOGE) canceled over $2.1 billion in NIH grants, including projects on LGBTQ+ youth health and transgender animal studies, citing taxpayer waste. 行政当局尚未根据报告宣布新政策。 The administration has not yet announced new policies based on the report.